J Infect Dis:张云研究组揭示细胞清除病原体新策略和效应分子

2017-04-29 佚名 昆明动物研究所

胞内细菌,病毒等细胞内感染病原体能够利用多种策略适应以及改变宿主细胞的胞内环境,逃脱宿主的免疫防御。许多胞内病原体利用细胞生理性的内吞囊泡途径侵染细胞,并适应了细胞内吞囊泡的酸化环境以达到其感染的目的。外源性的化学物质如氯化铵和氯喹等可以通过改变细胞内吞囊泡的酸化环境而抑制某些病毒和胞内寄生虫的感染,但宿主细胞是否存在相应的防御策略,内源性效应分子机器的身份以及调控网络一直是人们努力探究的重要问题

胞内细菌,病毒等细胞内感染病原体能够利用多种策略适应以及改变宿主细胞的胞内环境,逃脱宿主的免疫防御。许多胞内病原体利用细胞生理性的内吞囊泡途径侵染细胞,并适应了细胞内吞囊泡的酸化环境以达到其感染的目的。外源性的化学物质如氯化铵和氯喹等可以通过改变细胞内吞囊泡的酸化环境而抑制某些病毒和胞内寄生虫的感染,但宿主细胞是否存在相应的防御策略,内源性效应分子机器的身份以及调控网络一直是人们努力探究的重要问题。

中科院昆明动物研究所生物毒素与人类疾病课题组在研究员张云带领下,前期从两栖动物大蹼铃蟾(Bombina maxima)中发现了脊椎动物第一个新型孔道形成蛋白和三叶因子复合物betagamma-CAT (发明专利ZL200810058028.5),并发现该内源性蛋白质机器具有刺激细胞囊泡化形成的特性,在细胞内吞/溶酶体途径中形成膜通道并激活炎症小体(Proc Natl Acad Sci USA 2014,111,6702,封面故事)。该课题组李盛安和刘龙等进一步深入揭示该复合物具有调控细胞内囊泡酸化环境的功能。在宿主免疫防御中,以细胞内病原体单核增生李斯特菌(Listera monocytogenes)为模型的研究表明该蛋白质机器可以限制李斯特菌从胞内囊泡的逃逸,并同时激发细胞外排驱逐胞内感染的病原体,有效抵御致死性的李斯特菌感染。论文以 Host pore-forming protein complex neutralizes the acidification of endocytic organelles to counteract intracellular pathogens为题在线发表在美国传染病学会会刊 Journal of Infectious Diseases上 。副研究员李盛安和博士研究生刘龙是文章第一作者,张云是文章通讯作者。

该研究不仅揭示了脊椎动物防御和清除细胞内病原体的新策略和效应分子,也为深入解析细胞囊泡化形成和调控的基础细胞生物学问题以及相关的生理病理作用提供了新思路和新线索,对于研发新的疾病治疗策略和药物也具有实际应用的意义。研究获得国家基金委-云南联合基金重点项目以及“云岭学者”的资助。

原始出处:

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2012230, encodeId=f2c6201223049, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Fri Feb 16 05:11:00 CST 2018, time=2018-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=192614, encodeId=a48c192614b4, content=学习一下觉得非常好, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Mon May 01 21:18:20 CST 2017, time=2017-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1478392, encodeId=11fd14e8392af, content=<a href='/topic/show?id=d1a55858e70' target=_blank style='color:#2F92EE;'>#新策略#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58587, encryptionId=d1a55858e70, topicName=新策略)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da0f7431516, createdName=12498568m52暂无昵称, createdTime=Mon May 01 06:11:00 CST 2017, time=2017-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1510634, encodeId=7e3015106340c, content=<a href='/topic/show?id=2efbe0807b1' target=_blank style='color:#2F92EE;'>#病原体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70807, encryptionId=2efbe0807b1, topicName=病原体)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6c210226313, createdName=xue8605, createdTime=Mon May 01 06:11:00 CST 2017, time=2017-05-01, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2012230, encodeId=f2c6201223049, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Fri Feb 16 05:11:00 CST 2018, time=2018-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=192614, encodeId=a48c192614b4, content=学习一下觉得非常好, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Mon May 01 21:18:20 CST 2017, time=2017-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1478392, encodeId=11fd14e8392af, content=<a href='/topic/show?id=d1a55858e70' target=_blank style='color:#2F92EE;'>#新策略#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58587, encryptionId=d1a55858e70, topicName=新策略)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da0f7431516, createdName=12498568m52暂无昵称, createdTime=Mon May 01 06:11:00 CST 2017, time=2017-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1510634, encodeId=7e3015106340c, content=<a href='/topic/show?id=2efbe0807b1' target=_blank style='color:#2F92EE;'>#病原体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70807, encryptionId=2efbe0807b1, topicName=病原体)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6c210226313, createdName=xue8605, createdTime=Mon May 01 06:11:00 CST 2017, time=2017-05-01, status=1, ipAttribution=)]
    2017-05-01 虈亣靌

    学习一下觉得非常好

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2012230, encodeId=f2c6201223049, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Fri Feb 16 05:11:00 CST 2018, time=2018-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=192614, encodeId=a48c192614b4, content=学习一下觉得非常好, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Mon May 01 21:18:20 CST 2017, time=2017-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1478392, encodeId=11fd14e8392af, content=<a href='/topic/show?id=d1a55858e70' target=_blank style='color:#2F92EE;'>#新策略#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58587, encryptionId=d1a55858e70, topicName=新策略)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da0f7431516, createdName=12498568m52暂无昵称, createdTime=Mon May 01 06:11:00 CST 2017, time=2017-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1510634, encodeId=7e3015106340c, content=<a href='/topic/show?id=2efbe0807b1' target=_blank style='color:#2F92EE;'>#病原体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70807, encryptionId=2efbe0807b1, topicName=病原体)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6c210226313, createdName=xue8605, createdTime=Mon May 01 06:11:00 CST 2017, time=2017-05-01, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2012230, encodeId=f2c6201223049, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Fri Feb 16 05:11:00 CST 2018, time=2018-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=192614, encodeId=a48c192614b4, content=学习一下觉得非常好, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Mon May 01 21:18:20 CST 2017, time=2017-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1478392, encodeId=11fd14e8392af, content=<a href='/topic/show?id=d1a55858e70' target=_blank style='color:#2F92EE;'>#新策略#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58587, encryptionId=d1a55858e70, topicName=新策略)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da0f7431516, createdName=12498568m52暂无昵称, createdTime=Mon May 01 06:11:00 CST 2017, time=2017-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1510634, encodeId=7e3015106340c, content=<a href='/topic/show?id=2efbe0807b1' target=_blank style='color:#2F92EE;'>#病原体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70807, encryptionId=2efbe0807b1, topicName=病原体)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6c210226313, createdName=xue8605, createdTime=Mon May 01 06:11:00 CST 2017, time=2017-05-01, status=1, ipAttribution=)]
    2017-05-01 xue8605

相关资讯

Science:肠道病原体能利用人体修复机制让我们病倒

导语:为什么一些食源性细菌会使我们生病?一篇9月16日发表在Science杂志上的一篇论文发现,肠道中的病原体引起损害,是因为它们能从原本用来修复细菌起初对肠道损害的免疫系统反应中获益。为什么一些食源性细菌会使我们生病?一篇9月16日发表在Science杂志上的一篇论文发现,肠道中的病原体引起损害,是因为它们能从原本用来修复细菌起初对肠道损害的免疫系统反应中获益。加州大学戴维斯分校的通讯作者And

Cell:胆固醇也好的一面:有助清除病原体

我们免疫系统的细胞通过将病原体包裹在一个被称作吞噬体(phagosome)的区室中来杀死它们。吞噬体经历程序性成熟,随后将病原体降解掉。与这种降解密切相关的是诸如动力蛋白(dynein)和驱动蛋白(kinesin)之类的纳米级“马达”蛋白主动运输细胞内的吞噬体。马达蛋白是很多类型生物运动的动力产生器。由这些马达蛋白携带的吞噬体起初在细胞边缘附近来回移动,随后通过与其他区室融合而成熟。随着时间的推移

PLoS Pathog:揭示病原体逃脱机体免疫系统的分子机理

机体中的免疫系统有多种方法能够应对来自外界(比如病原体)的威胁,其中一种防御性机制就是自体吞噬过程(简称为自噬),我们可以将自噬想象成一种细胞吸尘器,其能够通过清除并且降解病原体或者细胞的破碎部分来维持细胞清洁,这就可以预防毒性废物的积累并且保护细胞的正常功能,自噬水平的降低在机体老化和

NAT COMMUN:为什么有些病原体对女性更温柔?

不少疾病对女性的致死率比对男性要低。通常我们会认为这是女性的免疫反应较强所致,但事情可能并没有那么简单。

《自然》新闻:准备研究世界上危险病原体的中国实验室

研究人员即将在武汉的一家实验室研究全世界最危险的病原体。中国计划到2025年在大陆建成5-7个生物安全四级实验室(BSL-4,国内也称P4实验室),武汉国家生物安全实验室就是其中之一,对此,外界反应喜忧参半。